Last reviewed · How we verify
EVONAIL® solution
At a glance
| Generic name | EVONAIL® solution |
|---|---|
| Also known as | Hydrating Nail Solution |
| Sponsor | Samsung Medical Center |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Efficacy of Evonail® Solution in the Prevention of Nail Damage Induced by Docetaxel in Patients With Breast Cancer. (NA)
- A Trial of Evonail® Solution for Prevention or Treatment of Onycholysis (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- EVONAIL® solution CI brief — competitive landscape report
- EVONAIL® solution updates RSS · CI watch RSS
- Samsung Medical Center portfolio CI